Question 1

How does Pinealon differ from Epithalon?

Accepted Answer

Both are Khavinson bioregulators, but they target different tissues. Epithalon (AEDG) targets the pineal gland's telomerase activity, while Pinealon (EDR) targets cortical neurons for neuroprotection. They are sometimes combined in longevity protocols.

Question 2

Is Pinealon orally bioavailable?

Accepted Answer

Tripeptides are generally degraded in the GI tract, but Khavinson's group claims these ultra-short peptides can survive digestion and penetrate cells due to their small size. Independent pharmacokinetic studies confirming oral bioavailability are limited.

Question 3

What is the evidence for Pinealon in cognitive decline?

Accepted Answer

Evidence comes primarily from Russian cell-culture work and small clinical observations in elderly patients, showing improvements in cognitive test scores and normalized circadian rhythms. Large controlled trials have not been conducted.

Question 4

Can Pinealon be combined with other nootropic peptides?

Accepted Answer

Practitioners sometimes combine it with Semax or Selank. No interaction studies exist. The theoretical rationale is that Pinealon works epigenetically on gene expression while Semax/Selank act on immediate neurotransmitter pathways — different mechanisms, minimal overlap.

Question 5

How long before noticing effects from Pinealon?

Accepted Answer

As a bioregulator proposed to work through gene-expression changes, effects are expected to be gradual — weeks rather than days. The standard Russian protocol recommends 10-day courses repeated several times per year, implying cumulative rather than acute benefit.

Question 6

Can Pinealon cross the blood-brain barrier?

Accepted Answer

According to research from the Khavinson group, Pinealon's extremely small size (just three amino acids, molecular weight ~418 Da) allows it to penetrate biological membranes including the blood-brain barrier without requiring active transport. In cell culture experiments, the tripeptide was shown to enter neurons and reach the nucleus, where it is proposed to interact with DNA regulatory regions. However, independent pharmacokinetic studies confirming BBB penetration in vivo — using standard methods like radiolabeled peptide tracking or cerebrospinal fluid sampling — have not been published by groups outside the Khavinson Institute. The claim is plausible given the peptide's tiny size but remains incompletely validated.

Question 7

How does Pinealon differ from melatonin supplementation?

Accepted Answer

Pinealon and melatonin operate through fundamentally different mechanisms despite both being associated with the pineal gland. Melatonin is a direct hormone supplement — you take the molecule itself, which binds MT1/MT2 receptors and produces immediate circadian and sleep effects. Pinealon is proposed to work epigenetically by modulating gene expression in pineal and cortical cells, potentially normalizing endogenous melatonin production rather than replacing it. The effects of melatonin are acute (same-night sleep improvement), while Pinealon's proposed effects are gradual and cumulative over weeks. They could theoretically be complementary, though no study has evaluated the combination.

Question 8

What is the Khavinson bioregulator theory?

Accepted Answer

The Khavinson bioregulator theory, developed by Professor Vladimir Khavinson at the Saint Petersburg Institute of Bioregulation and Gerontology, proposes that short peptides (2-4 amino acids) derived from organ-specific tissue extracts can regulate gene expression in their tissue of origin. The theory holds that aging involves a decline in tissue-specific peptide signaling, and that administering these short peptides can restore youthful gene expression patterns. Khavinson's group has identified dozens of these bioregulatory peptides for different organs — Epithalon for the pineal gland, Pinealon for brain tissue, Vilon for the thymus, and others. While the theory has generated hundreds of publications in Russian journals, independent replication and rigorous mechanistic validation in Western research labs remains limited.

Question 9

Is Pinealon available as an oral supplement?

Accepted Answer

Yes. Pinealon is most commonly sold in oral capsule form, typically at 10 mg doses, and is also available as a sublingual preparation. The Khavinson group claims that tripeptides this small can survive gastrointestinal digestion and be absorbed intact, unlike larger peptides that are broken down by digestive enzymes. This claim is somewhat controversial — most peptides require injection to avoid degradation. However, di- and tripeptides do have dedicated intestinal transporters (PepT1) that can absorb them intact, lending some biological plausibility to oral bioavailability for a tripeptide. Independent pharmacokinetic confirmation of oral absorption remains limited.

Origin / Manufacturer	Synthetic
Active Components	Pinealon tripeptide (Glu-Asp-Arg)Mannitol (filler, capsule form)
Storage	Room temperature, protected from moisture
Shelf Life	36 months (capsule form)
Form Factor	Capsules (typically 10 mg) or sublingual

Pinealon

Specifications

Frequently Asked Questions

Related Peptides

Cerebrolysin

Epitalon

Selank

Semax